FDA Inspection 1109239 - Gland Pharma Limited, Units I+II Pashamylaram Site - November 07, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on November 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: November 7, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · b1e79e8a-4766-4a82-8ce3-2f50924d5757

Violation Codes4

21 CFR 211.160(b)21 CFR 211.19221 CFR 211.46(b)21 CFR 211.84(b)

Full citation text and observation details available on the Dashboard.